Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome

US Patent 7928243 · Granted Apr 19, 2011

Estimated economic value: $23,244,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and apparatus to mitigate word line staircase etch stop layer thickness v2025
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)2025
Smart battery swapping station compatible with multiple battery packs, control m2025
Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-d2025
Method for interactive plot jumping, method for displaying interactive plot inte2025
Infrared stealth cloth and infrared stealth clothes2025
Bipyrazole derivatives as JAK inhibitors2025
Apparatus and methods for controlled drug waste diversion detection2025
Video playing method and apparatus2025
Salts of TAM inhibitors2025
Infrared detector and infrared imager2024
Heterocyclic compounds as kinase inhibitors, compositions comprising the heteroc2024